Product NDC: | 0145-0071 |
Proprietary Name: | VELTIN |
Non Proprietary Name: | clindamycin phosphate and tretinoin |
Active Ingredient(s): | 10; .25 mg/g; mg/g & nbsp; clindamycin phosphate and tretinoin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0145-0071 |
Labeler Name: | Stiefel Laboratories Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050803 |
Marketing Category: | NDA |
Start Marketing Date: | 20100729 |
Package NDC: | 0145-0071-02 |
Package Description: | 1 TUBE in 1 BLISTER PACK (0145-0071-02) > 2 g in 1 TUBE (0145-0071-03) |
NDC Code | 0145-0071-02 |
Proprietary Name | VELTIN |
Package Description | 1 TUBE in 1 BLISTER PACK (0145-0071-02) > 2 g in 1 TUBE (0145-0071-03) |
Product NDC | 0145-0071 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate and tretinoin |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20100729 |
Marketing Category Name | NDA |
Labeler Name | Stiefel Laboratories Inc |
Substance Name | CLINDAMYCIN PHOSPHATE; TRETINOIN |
Strength Number | 10; .25 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient],Retinoid [EPC],Retinoids [Chemical/Ingredient] |